228760 — Genomictree Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Market Cap
KR₩350bn
Enterprise Value
KR₩256bn
Revenue
KR₩2bn

Annual balance sheet for Genomictree, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	103,119	130,531	114,605	86,146	96,080
Net Total Accounts Receivable
Net Total Receivables	388	2,878	1,691	1,115	918
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	105,300	134,327	118,000	95,371	97,662
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10,633	21,459	17,866	17,460	18,386
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	117,896	177,151	162,910	132,844	130,675
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4,090	2,142	53,442	5,281	4,751
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	22,640	62,050	55,855	8,108	6,791
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity	95,255	115,101	107,055	124,736	123,885
Total Liabilities & Shareholders' Equity	117,896	177,151	162,910	132,844	130,675
Total Common Shares Outstanding
Total Preferred Shares Outstanding